Drug intelligence / Profile preview

Biale ACTIVE

Development stage: Unknown
Lead developer: Astrapharm
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Biale ACTIVE is a dietary supplement formulated as a synbiotic, combining probiotic cultures (specifically Canadian yogurt cultures) with fructooligosaccharides, which act as prebiotics. Developed by Astrapharm, it is designed to support gastrointestinal health by maintaining the balance of intestinal microflora. It is primarily indicated for individuals experiencing irritable bowel syndrome (IBS), situational constipation, or those requiring digestive support during dietary changes or travel. The product is administered orally in the form of gelatin capsules and works by introducing beneficial bacteria and their growth substrates into the gut environment.

Brand names: Biale ACTIVE
Other names: Biale ACTIVE Canadian yogurt + fructooligosaccharides

Beyond the preview

Go deeper on Biale ACTIVE.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biale ACTIVE.

Explore the full profile